TRANSCEND CAPITAL ADVISORS, LLC
Position in AQST — Aquestive Therapeutics, Inc.
CIK 1776082
MADISON, NJ
Position in AQST
as of Jun 30, 2026
· filed Aug 4, 2026
Position Value
$131,085
-$26,316 QoQ
Shares Held
31,511
-16.9% QoQ
Ownership
0.025%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#92
of 185 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in AQST Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026TRANSCEND CAPITAL ADVISORS, LLC holds $1,617,958 across 4 Drug Manufacturers - Specialty & Generic names. AQST ranks #4 (8.1% of the industry book) .
All Filings in AQST
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $131,085 | 31,511 | Shares | Sole | 2026-08-04 | |
| 2026-03-31 | $157,401 | 37,928 | Shares | Sole | 2026-05-13 | |
| No filing history on record for this holder in this stock. | ||||||